AMGN logo Amgen : AMGN

AMGN

Stock Data

$332.64

Change down

$7.52 (2.21%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

DRUG MANUFACTURERS - GENERAL

Amgen Inc. is a biotechnology pioneer focused on developing and delivering innovative human therapeutics. Its portfolio includes treatments for serious illnesses such as rheumatoid arthritis, psoriasis, osteoporosis, and various types of cancer. Among its well-known products are Enbrel, Otezla, Prolia, and Repatha. Amgen also collaborates with other pharmaceutical giants to enhance its product offerings, demonstrating a commitment to improving patient health globally. Founded in 1980, Amgen has grown to serve healthcare providers and patients worldwide from its headquarters in Thousand Oaks, California.

All Amgen Articles

691 Articles

1 2 3 47

Our $500K AI Portfolio

See us invest in our favorite AI stock ideas for free

Our Investment Portfolio